Skip to Main Navigation

Peru COVID-19 Vaccination Project

Abstract*

The proposed Project will focus on the procurement of COVID-19 vaccines to further implement the COVID-19 vaccination plan in Peru. The project will build on the experiences and achievements of similar project under implementation in the region and around the world. The project will have one technical component that will support the procurement of COVID-19 vaccines, and a Project management component.

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To increase COVID-19 vaccination coverage among the population of Peru.

Key Details

Project Details

  • P178181

  • Closed

  • Carlos Bortman , Malva Baskovich

  • Republic of Peru

  • Peru

  • November 18, 2021

  • (as of board presentation)

    December 20, 2021

  • N/A

  • US$ 500.00 million

  • N/A

  • Substantial

  • October 28, 2022

  • No

  • BANK APPROVED

  • April 25, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 500.00
Borrower/Recipient 3.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 500.00
IDA Commitment N/A
IBRD + IDA Commitment 500.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 503.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Oct 28, 2022 IBRD-93270 Loan Cancel 500,000,000.00
Dec 20, 2021 IBRD-93270 Loan Commitment 500,000,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Project Management Satisfactory 2022-03-29
Counterpart Funding Satisfactory 2022-03-29
Monitoring and Evaluation Satisfactory 2022-03-29
Overall Implementation Progress (IP) Satisfactory 2022-03-29
Progress towards achievement of PDO Satisfactory 2022-03-29
Procurement Satisfactory 2022-03-29
Financial Management Satisfactory 2022-03-29

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of total population vaccinated with WB financed vaccines (total and disaggregated by sex)Value0.000.0062.00
    DateOctober 22, 2021March 9, 2022December 29, 2023
    Comment
  • Reduction of gender gap in COVID-19 vaccination ratio (Female/Male) (disaggregation by age group)Value1.301.061.10
    DateNovember 2, 2021March 1, 2022December 29, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of Vaccines contracts included in STEPValue0.000.002.00
    DateNovember 1, 2021March 9, 2022December 29, 2023
    Comment
  • Number of reports issued by the "Vaccine deployment oversight and assurance mechanism"Value1.001.005.00
    DateNovember 1, 2021March 9, 2022December 29, 2023
    Comment
  • Number of COVID-19 vaccine doses acquired through project financingValue0.000.0040000000.00
    DateNovember 15, 2021March 9, 2022December 29, 2023
    Comment
  • Number of actions taken in vaccine deployment and distribution based on feedback from beneficiaries.Value0.000.0015.00
    DateNovember 16, 2021March 9, 2022December 29, 2023
    Comment
  • Percentage of vaccine recipients satisfied with their experience (Total and disaggregated by sex and ethnicity)Value0.000.0066.00
    DateDecember 3, 2021March 9, 2022June 30, 2023
    Comment